CADIAN CAPITAL MANAGEMENT, LP: EVOLENT HEALTH INC (EVH): Quarterly 13F Position History
As of Q2 2026, CADIAN CAPITAL MANAGEMENT, LP reported 10,814,473 shares of EVOLENT HEALTH INC (EVH), worth $58.6M and representing 4.4% of its 13F equity book. The position first appeared in Q3 2017 and has been disclosed across 36 13F-HR filings in Pactolio's tracked window.
- 10,814,473Shares Held (Latest Filing)
- $58.6MReported Market Value (Latest Filing)
- 4.4%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- +$34.0MQuarter-over-Quarter Value Change
- 11,728,924Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 36 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,814,473 | 0 | – | $58.6M | 4.4% | $5.4 |
| Q1 2026 | 10,814,473 | 270,982 | -2.4% | $24.7M | 3.0% | $2.3 |
| Q4 2025 | 11,085,455 | 643,469 | -5.5% | $44.3M | 3.2% | $4.0 |
| Q3 2025 | 11,728,924 | +1,304,223 | +12.5% | $99.2M | 5.9% | $8.5 |
| Q2 2025 | 10,424,701 | 369,905 | -3.4% | $117.4M | 6.6% | $11.3 |
| Q1 2025 | 10,794,606 | +5,569,605 | +106.6% | $102.2M | 4.4% | $9.5 |
| Q4 2024 | 5,225,001 | +5,225,001 | – | $58.8M | 3.4% | $11.3 |
| Q3 2024 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2024 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2024 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2023 | 0 | 0 | – | $0 | 0.0% | – |
| Q3 2023 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2023 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2023 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2022 | 0 | 0 | – | $0 | 0.0% | – |
| Q3 2022 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2022 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2022 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2021 | 0 | 0 | – | $0 | 0.0% | – |
| Q3 2021 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2021 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2021 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2020 | 0 | 0 | – | $0 | 0.0% | – |
| Q3 2020 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2020 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2020 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2019 | 0 | 0 | – | $0 | 0.0% | – |
| Q3 2019 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2019 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2019 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2018 | 0 | 0 | – | $0 | 0.0% | – |
| Q3 2018 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2018 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2018 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2017 | 0 | 940,000 | -100.0% | $0 | 0.0% | – |
| Q3 2017 | 940,000 | – | – | $16.7M | 0.8% | $17.8 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did CADIAN CAPITAL MANAGEMENT, LP first disclose a EVH position in 13F-HR filings?
CADIAN CAPITAL MANAGEMENT, LP first reported EVOLENT HEALTH INC (EVH) on its 13F-HR filing for the period ending 2017-09-30 (Q3 2017). The position has appeared on 36 reported quarters within Pactolio's tracked window.
What was CADIAN CAPITAL MANAGEMENT, LP's most recent quarter-over-quarter share-count change in EVH?
CADIAN CAPITAL MANAGEMENT, LP held the same 10,814,473 shares of EVH between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent CADIAN CAPITAL MANAGEMENT, LP's cost basis in EVH?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.